Product image of Norditropin Simplexx (Somatropin) supplied by GNH India

Norditropin Simplexx

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Simplexx (Somatropin)

Somatropin, the active ingredient in Norditropin Simplexx, is a human growth hormone presented as a solution for injection (prefilled pen) for subcutaneous use. It treats growth hormone deficiency in children and adults and related endocrine disorders.

GNH India supplies Norditropin Simplexx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Simplexx (somatropin) is used in endocrine therapy to replace deficient growth hormone.

  • Growth hormone deficiency in children: promotes normal linear growth and improves body composition.
  • Growth hormone deficiency in adults: enhances metabolic function, reduces fat mass and improves quality of life.
  • Turner syndrome: supports height increase during puberty.
  • Prader‑Willi syndrome: aids in improving growth and body composition.
  • Chronic renal insufficiency associated growth failure: stimulates growth in children with renal disease.
  • Idiopathic short stature: facilitates catch‑up growth when other causes are excluded.

How It Works

  • Somatropin is a recombinant form of human growth hormone that binds to the growth hormone receptor on target cells. Receptor activation triggers the JAK2‑STAT5 signaling cascade, leading to increased hepatic synthesis of insulin‑like growth factor‑1 (IGF‑1). Elevated IGF‑1 mediates the anabolic and metabolic actions of growth hormone, promoting linear bone growth, protein synthesis, lipolysis and carbohydrate metabolism.

Side Effects

Somatropin therapy may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Injection site pain: mild discomfort or erythema at the injection site.
  • Headache: transient headache reported by some patients.
  • Joint pain: arthralgia, especially in the knees and hips.
  • Edema: peripheral swelling, often in the ankles.
  • Hyperglycemia: elevated blood glucose levels.
  • Fatigue: general tiredness or lack of energy.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include headache, visual disturbances and papilledema.
  • Slipped epiphysis (epiphyseal plate fracture): risk of growth plate injury in rapidly growing children.
  • Severe allergic reaction: anaphylaxis, urticaria or angioedema requiring immediate medical attention.

Precautions & Warnings

When prescribing somatropin, clinicians should observe several precautions to ensure safe and effective use.

  • Monitor IGF‑1 levels: adjust dose to maintain IGF‑1 within age‑appropriate reference range.
  • Screen for diabetes: regularly check fasting glucose and HbA1c.
  • Assess for intracranial hypertension: watch for persistent headache, visual changes or nausea.
  • Avoid use in active malignancy: growth hormone may stimulate tumor growth.
  • Contraindicated in hypersensitivity to somatropin or formulation components: discontinue if allergic reaction occurs.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Insulin: somatropin may reduce insulin sensitivity, requiring dose adjustments.
  • Glucocorticoids: high‑dose steroids can antagonize growth‑promoting effects.
  • Oral estrogen therapy: may diminish IGF‑1 response, necessitating higher somatropin doses.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: somatropin can increase thyroid hormone requirements; monitor thyroid function tests.
  • Diuretics: may exacerbate edema; observe fluid balance.
  • Antidiabetic agents: monitor glucose control as somatropin may cause hyperglycemia.

Frequently Asked Questions

Norditropin Simplexx contains somatropin, a recombinant human growth hormone. It is prescribed to replace deficient growth hormone in children with growth failure, in adults with growth hormone deficiency, and in specific conditions such as Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency‑related growth failure, and idiopathic short stature.

Somatropin binds to growth hormone receptors on cell surfaces, activating the JAK2‑STAT5 signaling pathway. This stimulates the liver to produce insulin‑like growth factor‑1 (IGF‑1), which drives bone growth, protein synthesis, lipolysis and metabolic regulation, thereby supporting normal growth and body composition.

The dose of Norditropin Simplexx is individualized by the prescribing clinician based on factors such as age, weight, severity of growth hormone deficiency, IGF‑1 levels, and response to therapy. No fixed regimen is provided; the prescriber adjusts the dose to achieve target IGF‑1 concentrations.

Safety of somatropin in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women of child‑bearing potential should use effective contraception during treatment.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics) and the necessary import documentation.

Norditropin Simplexx is a recombinant somatropin delivered in a prefilled pen, offering precise dosing and ease of subcutaneous injection. Compared with vial‑based formulations, the pen reduces preparation steps and dosing errors. Efficacy and safety are comparable to other approved somatropin products when used according to prescribing information.

Norditropin Simplexx should be stored in a refrigerator at 2‑8 °C (36‑46 °F). Keep the pen in its original carton, protect it from light, and avoid freezing or shaking. Once in use, follow the manufacturer’s guidance on the period the pen can remain at room temperature.

The product is supplied as a solution for injection in a prefilled pen. It is administered subcutaneously, typically into the thigh, abdomen or upper arm, according to the dose set by the prescriber. Patients or caregivers should be trained on proper injection technique and pen handling.

Serious risks include intracranial hypertension, slipped epiphysis (growth‑plate fracture), and severe allergic reactions such as anaphylaxis. Monitoring for persistent headache, visual changes, joint pain, or signs of hypersensitivity is essential, and any concerning symptoms should prompt immediate medical evaluation.

Norditropin Simplexx is contraindicated in individuals with known hypersensitivity to somatropin or any excipients in the formulation. It should also be avoided in patients with active malignancy, uncontrolled diabetes, or those who have experienced severe adverse reactions to growth hormone therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT